The heterozygous IFIH1 missense mutations underlying several autosomal dominant autoimmune disorders, namely SLE, AGS and SMS, enhance interferon beta induction by MDA5, opposed to the IFIH1 nonsense mutation of patient II:1 which can be considered recessive (heterozygous carriers – the parents and the patient’s sister – are healthy). This evidence concerns the gene IFIH1 and Smith-Magenis syndrome.